develop
antisever
acut
respiratori
syndrom
associ
coronaviru
sarscov
agent
pivot
prevent
reemerg
lifethreaten
diseas
sar
studi
extract
chines
medicin
herb
evalu
antisarscov
activ
use
cellbas
assay
measur
sarscovinduc
cytopathogen
effect
cpe
vitro
vero
cell
six
herbal
extract
one
gentiana
radix
dri
rhizom
gentiana
scabra
dioscorea
rhizoma
tuber
dioscorea
batata
cassia
semen
dri
seed
cassia
tora
loranthi
ramu
dri
stem
leaf
taxillu
chinensi
design
gsh
dbm
cth
tch
respect
two
rhizoma
cibotii
dri
rhizom
cibotium
barometz
design
cbe
cbm
found
potent
inhibitor
sarscov
concentr
concentr
six
extract
need
inhibit
vero
cell
prolifer
cc
viral
replic
ec
determin
result
select
index
valu
si
cc
ec
effect
extract
cbe
gsh
dbm
cth
tch
respect
among
extract
cbm
dbm
also
show
signific
inhibit
sarscov
proteas
activ
ic
valu
respect
find
suggest
six
herbal
extract
may
potenti
candid
futur
develop
antisar
therapeut
sever
acut
respiratori
syndrom
sar
highli
infecti
lifethreaten
diseas
caus
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
ksiazek
et
al
kuiken
et
al
sar
spread
quickli
countri
caus
probabl
sar
case
sarsrel
death
although
variou
candid
drug
subsequ
report
attenu
diseas
hoever
et
al
holm
current
still
clinic
approv
recommend
antivir
drug
specif
sar
use
current
frequent
treatment
sar
antivir
support
treatment
use
combin
ribavirin
corticosteroid
et
al
howev
ribavirin
margin
effect
sar
viru
show
seriou
advers
side
effect
stroher
et
al
sinc
sar
outbreak
consider
effort
put
antivir
research
evalu
drug
candid
antisarscov
activ
prevent
possibl
reemerg
diseas
wen
et
al
notabl
glycyrrhizin
licoric
root
number
glycyrrhizin
deriv
shown
possess
demonstr
antisarscov
bioactiv
nonsteroid
antiinflammatori
drug
indomethacin
also
found
confer
potent
antivir
activ
sarscov
amici
et
al
number
tradit
herbal
medicin
also
report
possess
antivir
activ
sarscov
chen
et
al
li
et
al
lin
et
al
ryu
et
al
sarscov
genom
encod
variou
key
protein
molecul
may
serv
potenti
target
chemotherapeut
inhibit
viral
infect
replic
lai
stadler
et
al
vital
target
includ
spike
protein
sarscov
main
proteas
proteas
ntpasehelicas
rnadepend
rna
polymeras
membran
protein
envelop
protein
e
nucleocapsid
phosphoprotein
n
possibl
viral
proteinmedi
process
de
clercq
gallagh
buchmeier
groneberg
et
al
holm
kliger
et
al
lai
stadler
et
al
antisarscov
agent
inhibit
sarscov
replic
may
involv
inhibit
one
protein
target
includ
sarscov
proteas
import
proteas
regul
proteolyt
process
replicas
polypeptid
function
protein
play
essenti
role
viral
replic
chen
et
al
kuo
et
al
sarscov
proteas
thu
attract
target
drug
candid
sar
studi
first
investig
effect
extract
tradit
chines
medicin
tcm
herb
antisarscov
activ
use
vero
cellbas
cytopathogen
effect
cpe
assay
herbal
extract
antisarscov
activ
shown
cpe
assay
subsequ
evalu
inhibit
sarscov
replic
use
elisa
bioactiv
extract
investig
inhibit
sarscov
proteas
activ
find
demonstr
six
previous
unreport
specif
herbal
extract
may
potenti
use
drug
target
futur
develop
antisar
therapeut
tradit
chines
medicin
herb
prepar
use
shown
figur
briefli
plant
materi
ground
powder
immers
volum
water
sonic
hour
filter
threefold
volum
ethanol
ad
filtrat
left
hour
centrifug
minut
supernat
rotorevapor
freezedri
obtain
e
fraction
ethanol
precipit
fraction
freezedri
obtain
w
fraction
previou
residu
mix
volum
methanol
left
hour
filter
obtain
two
fraction
filtrat
residu
filtrat
rotorevapor
freezedri
obtain
fraction
residu
mix
volum
nhexan
sonic
hour
kept
overnight
filter
rotorevapor
freezedri
obtain
filtrat
h
plant
materi
code
first
letter
name
genu
speci
follow
abbrevi
prepar
method
exampl
w
e
h
extract
cibotium
barometz
abbrevi
cbw
cbe
cbm
cbh
respect
eight
well
prepar
test
extract
three
well
contain
virusinfect
test
extract
posit
control
cpe
three
well
contain
virusinfect
extract
treatment
two
well
contain
extract
treatment
without
viral
infect
brief
vero
cell
well
cultur
plate
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
incub
co
one
day
cell
reach
confluenc
cultur
medium
remov
replenish
dmem
supplement
fb
test
cell
cultur
confluenc
treat
without
test
extract
dmem
fb
medium
two
hour
later
test
cell
cultur
medium
incub
sarscov
hong
kong
strain
dose
tcid
tissu
cultur
infecti
dose
per
well
cytopathogen
morpholog
cell
observ
evalu
hour
post
infect
use
invert
phase
contrast
microscopi
inhibit
sarscov
mediat
cpe
test
extract
classifi
three
level
previous
report
tan
et
al
cell
cultur
less
vero
cell
show
cytopathogen
morpholog
respons
sarscov
treatment
extract
score
cell
cultur
cell
show
cytopathogen
morpholog
score
respect
assay
protocol
report
previous
wen
et
al
briefli
vero
cell
well
cultur
plate
dmem
supplement
fb
co
incub
incub
one
day
cultur
cell
reach
confluenc
cultur
medium
replenish
fresh
dmem
medium
contain
fb
test
extract
vari
concentr
place
microwel
incub
day
test
cultur
medium
replenish
fresh
cultur
medium
contain
bromid
mtt
concentr
mgml
per
well
hour
optic
densiti
od
measur
spectrophotomet
nm
surviv
vero
cell
treatment
calcul
use
formula
viabl
cell
number
od
treat
cell
od
vehicl
control
cell
cc
valu
taken
test
compound
concentr
cell
viabil
reduc
inhibitori
effect
test
extract
sarscov
replic
measur
previous
describ
wen
et
al
briefli
test
extract
ad
vero
cell
incub
day
sarscov
cell
gentli
rins
pb
three
time
fix
formalin
minut
room
temperatur
formalin
remov
cell
fix
methanolaceton
vv
solut
minut
room
temperatur
cell
block
skim
milk
pb
hour
room
temperatur
rins
three
time
pb
incub
hour
dilut
monoclon
antibodi
spike
protein
sarscov
sampl
rins
three
chang
pb
contain
tween
pbst
buffer
follow
wash
twice
fresh
pb
room
temperatur
final
rins
skim
milk
pbst
buffer
cell
incub
horseradish
peroxidaseconjug
goat
antimous
igg
minut
room
temperatur
rins
three
time
pbst
buffer
substrat
solut
contain
phenylenediamin
dihydrochlorid
citrat
buffer
ph
hydrogen
peroxid
ad
well
plate
cover
gentli
shaken
room
temperatur
minut
dark
reaction
stop
addit
n
sulfur
acid
absorb
read
immedi
nm
elisa
reader
ec
valu
test
compound
calcul
linear
regress
plot
compound
concentr
versu
od
gene
encod
sarscov
main
proteas
clone
whole
viral
genom
polymeras
chain
reaction
pcr
primer
insert
forward
primer
revers
primer
vector
report
previous
chen
et
al
kuo
et
al
recombin
proteas
plasmid
transform
e
coli
compet
cell
streak
luriabertani
lb
agar
plate
contain
ampicillin
correct
construct
subsequ
transform
e
coli
host
cell
express
histag
protein
digest
fxa
proteas
remov
tag
purifi
protein
confirm
ntermin
sequenc
mass
spectrometri
analysi
antisarscov
activ
test
extract
first
measur
use
cellbas
assay
cytopathogen
effect
infect
vero
cell
describ
previous
wen
et
al
figur
panel
show
origin
morpholog
vero
cell
without
treatment
test
extract
neg
control
panel
b
show
cytopath
morpholog
sarscovinfect
vero
cell
posit
control
inhibit
sarscov
mediat
cpe
vero
cell
grade
three
level
repres
least
inhibit
repres
inhibit
shown
panel
c
e
respect
valinomycin
val
previous
report
exhibit
strong
antisar
bioactiv
vitro
employ
refer
control
high
inhibit
level
tabl
among
test
extract
none
w
fraction
test
plant
materi
confer
signific
antisar
activ
e
h
fraction
herbal
extract
six
extract
cbe
cbm
rhizoma
cibotii
dri
rhizom
cibotium
barometz
gsh
gentiana
radix
dri
rhizom
gentiana
scabra
dbm
dioscorea
rhizoma
tuber
dioscorea
batata
cth
cassia
semen
dri
seed
cassia
tora
tch
loranthi
ramu
dri
stem
leaf
taxillu
chinensi
design
gsh
dbm
cth
tch
respect
two
show
inhibitori
activ
level
cpe
assay
concentr
tabl
evalu
whether
vehicl
solvent
dmso
result
possibl
cytotox
neg
effect
vero
cell
mtt
assay
microscop
examin
perform
result
show
littl
cytotox
effect
detect
dmsotreat
cell
good
agreement
previou
find
wen
et
al
investig
whether
six
herbal
extract
exhibit
potent
inhibitori
activ
could
significantli
inhibit
viral
replic
level
spike
protein
sarscov
infect
vero
cell
without
treatment
test
extract
measur
elisa
seen
figur
six
extract
show
antisarscov
replic
activ
concentr
detect
elisa
concentr
test
extract
requir
inhibit
viral
replic
ec
calcul
summar
tabl
contrast
cbm
ec
valu
higher
ec
valu
cbe
gsh
dbm
cth
tch
determin
respect
although
valu
fold
higher
refer
compound
valinomycin
val
ec
consider
low
ec
valu
extract
interest
may
suggest
test
extract
appar
significantli
inhibit
sarscov
replic
specif
sinc
possibl
antisarscov
activ
test
extract
may
result
direct
inhibit
growth
test
vero
cell
mtt
assay
thu
conduct
evalu
potenti
cytotox
effect
test
phytoextract
concentr
rang
vero
cell
seen
tabl
proteas
activ
proteolyt
cleavag
viral
polyprotein
specif
site
proteas
play
import
role
sarscov
replic
chen
et
al
understand
whether
antisarscov
activ
extract
result
inhibit
sarscov
proteas
activ
six
test
extract
evalu
proteas
inhibit
assay
ic
valu
extract
measur
use
quench
fluoresc
energi
transfer
fret
method
previous
describ
niclosamid
nic
report
inhibitor
sarscov
proteas
activ
use
refer
control
nic
ic
valu
studi
seen
figur
tabl
among
extract
test
cbm
dbm
confer
consider
inhibit
sarscov
proteas
activ
ic
valu
respect
ic
valu
test
extract
higher
sinc
outbreak
sar
consider
effort
put
research
diseas
howev
date
drug
approv
potenti
futur
clinic
use
patient
sar
cleri
et
al
assur
adequ
public
safeti
control
infect
event
reemerg
ill
effect
antisarscov
agent
may
still
highli
desir
even
necessari
plant
materi
especi
previous
use
tradit
chines
medicin
believ
rich
resourc
develop
relat
therapeut
agent
drug
candid
studi
employ
cellbas
cytopathogen
effect
cpe
assay
sarscovinfect
vero
cell
screen
extract
candid
antisarscov
activ
six
herbal
extract
tradit
chines
medicin
herb
found
exhibit
signific
level
antisarscov
activ
concentr
tabl
measur
compar
result
cpe
assay
level
antisarscov
activ
better
report
glycyrrhizin
compound
known
antisarscov
activ
extract
tradit
herb
previous
report
confer
antisarscov
activ
lau
et
al
li
et
al
cpe
viral
infect
may
involv
complex
interact
number
molecular
mechan
sarscov
test
vero
cell
stadler
et
al
quantif
amount
spike
protein
present
sarscovinfect
vero
cell
ec
show
antisarscov
activ
extract
may
act
specif
inhibit
viral
replic
tabl
figur
addit
mtt
assay
adopt
determin
cc
test
extract
data
led
us
suggest
antivir
activ
detect
appar
due
effect
cytotox
test
extract
host
cell
evidenc
low
ec
extract
select
index
si
valu
calcul
ratio
cc
ec
indic
potenc
test
phytoextract
comparison
posit
control
valinomycin
val
cbe
gsh
dbm
cth
tch
show
potent
activ
cpe
also
exhibit
mark
inhibitori
effect
sarscov
replic
si
valu
tabl
five
bioactiv
extract
significantli
higher
even
si
valu
posit
control
valinomycin
si
si
valu
five
extract
also
higher
two
tradit
chines
herb
previous
report
inhibit
sarscov
infect
cinnamomi
cortex
shown
inhibit
sarscov
infect
si
valu
toona
sinensi
extract
shown
inhibit
sarscov
replic
si
valu
chen
et
al
taken
togeth
henc
suggest
six
tcm
phytoextract
report
inhibit
sarscov
replic
littl
cytotox
vero
cell
may
thu
serv
use
candid
futur
develop
antisar
therapeut
sarscov
proteas
involv
viral
matur
process
cleav
virusencod
polyprotein
chen
et
al
pivot
role
sarscov
life
cycl
proteas
recogn
import
target
discoveri
antisarscov
agent
among
extract
test
inhibit
sarscov
proteas
activ
ic
valu
cbm
dbm
suggest
two
extract
exhibit
signific
inhibitori
activ
proteas
number
studi
contribut
identif
inhibitor
sarscov
proteas
howev
ic
valu
cbm
dbm
inhibit
sarscov
proteas
also
similar
higher
extract
antisarscov
medicin
herb
report
date
includ
isati
indigotica
ic
li
et
al
torreya
nucifera
ic
tea
extract
ic
houttuynia
cordata
ic
lau
et
al
therefor
suggest
herbal
extract
cbm
dbm
may
use
drug
candid
sarscov
proteas
may
potenti
use
altern
herbal
therapi
sar
four
herbal
extract
test
two
herbal
extract
may
inhibit
sarscov
replic
via
differ
work
mechan
includ
block
viral
bind
inhibit
sarscov
fusion
host
cell
inhibit
activ
sarscov
proteas
inhibit
rna
transcript
kliger
et
al
recent
phytochem
extract
deriv
tradit
use
medicin
plant
herb
contempl
clinic
evalu
altern
complementari
treatment
variou
diseas
previou
report
show
cibotium
barometz
inhibit
osteoclast
format
antioxid
tyrosinas
inhibit
antibacteri
activ
cuong
et
al
lai
et
al
studi
cibotium
barometz
found
possess
good
antisarcov
activ
effect
inhibit
sar
conclus
proteas
activ
bioactiv
compon
respons
activ
therefor
warrant
investig
gentiana
scabra
previous
shown
confer
hepatoprotect
effect
jiang
xue
contain
triterpenoid
secoiridoid
glycosid
chueh
et
al
kakuda
et
al
kim
et
al
base
previou
studi
antisarscov
phytocompound
wen
et
al
specif
triterpenoid
shown
inhibit
sarscov
replic
therefor
suggest
secoiridoid
glycosid
may
contribut
antisar
activ
detect
gentiana
scabra
extract
secoiridoid
glycosied
may
potenti
evalu
antisar
lead
compound
previou
studi
su
et
al
su
et
al
two
specif
polysaccharidecontain
fraction
dioscorea
batata
tuber
extract
significantli
increas
gmcsf
promot
activ
normal
inflam
skin
enhanc
murin
splenocyt
prolifer
ex
vivo
improv
regener
bone
marrow
cell
vivo
studi
also
reveal
ethanol
extract
dioscorea
batata
exert
antiinflammatori
effect
inhibit
ino
express
jin
et
al
interfer
express
may
correl
antisarscov
antivir
activ
amici
et
al
kim
et
al
therefor
hypothes
antisarscov
activ
demonstr
may
result
inhibit
activ
cassia
tora
found
confer
antihypertens
hyun
et
al
antihyperlipidemia
cho
et
al
antibacteri
hatano
et
al
antifung
properti
kim
et
al
anthraquinon
includ
emodin
physcion
rhein
may
activ
phytocompound
confer
activ
kim
et
al
wu
yen
emodin
alreadi
found
exhibit
antisarscov
activ
via
inhibit
viral
entri
bind
spike
protein
interf
sarscov
proteas
activ
hypothes
activ
phytochem
compon
respons
antisarscov
activ
cth
may
contribut
emodin
anoth
anthraquinon
suggest
known
present
cth
taxillu
chinensi
shown
inhibit
fatti
acid
synthas
wang
et
al
base
previou
studi
yi
et
al
show
luteolin
quercetin
interfer
entri
viru
host
cell
therefor
hypothes
specif
glycosyl
flavonoid
quercetin
may
play
effect
role
activ
whether
flavonoid
also
contribut
detect
antisar
activ
warrant
futur
investig
summari
studi
show
six
phytoextract
rhizoma
cibotii
gentiana
radix
dioscorea
rhizoma
cassia
semen
loranthi
ramu
confer
effect
antisarscov
activ
via
inhibit
sarscov
replic
cbm
dbm
extract
also
inhibit
proteas
activ
sarscov
find
suggest
phytoextract
studi
tcm
experi
may
valu
use
approach
futur
develop
antisarscov
therapeut
agent
